Alychlo
Alychlo NV is a venture capital and private equity firm based in Merelbeke, Belgium, established in 2008. The firm focuses on both direct and indirect investments, with direct investments targeting sectors such as healthcare, particularly life sciences and biotechnology, as well as hospitality and leisure. Alychlo specializes in various investment strategies including middle market, later stage, turnaround, and growth capital investments, often preferring minority stakes. The firm's indirect investments encompass private equity and venture capital funds, in addition to real estate funds. Alychlo typically invests between 10 million and 50 million euros and is particularly active in the European market, with a strong emphasis on Belgium. The firm also engages in secondary investing, allowing for portfolio company interests.
Itineris develops and implements UMAX, a cloud-based CIS & CRM solution specifically designed for Utilities. UMAX leverages workflow automation and AI to easily manage everything from meter to cash, advanced revenue collection, assets, complex rates, conservation, marketing and campaign programs, and much more to ensure advanced customer engagement and streamlined business processes. UMAX is developed on the powerful Microsoft Dynamics 365 platform, and is delivered as a service in the Microsoft Azure Cloud. Founded in 2003, Itineris has an impressive implementation track record. Our customer base includes De Watergroep (Belgium), Eneco (the Netherlands), SSE (UK), Flogas (Ireland), The New York Department of Environmental Protection (US), Boston Water and Sewer Commission (US), and the City of Tallahassee (US), to name a few. With our software solutions, we want to empower utility professionals to play their part in the new world of energy and water.
SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory and biopharma institutions globally.
SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory and biopharma institutions globally.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.